Allermi
Company

Last deal

Amount

Series A

Stage

01.04.2024

Date

5

all rounds

$4.8M

Total amount

General

About Company
Allermi delivers customized prescription allergy medications directly to consumers.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2019

Number of employees

Last funding type

Series A

IPO status

Private

Description

Allermi is revolutionizing the allergy medication industry by offering consumers direct access to customized prescription treatments designed by world-class allergists. Through their platform, patients can connect with board-certified allergists and receive science-based medicine tailored to their specific symptoms. Allermi's skincare products use natural, preservative-free, FDA-approved and clinically-proven ingredients to create personalized nasal allergy and eczema treatments with varying concentrations of active ingredients. With Allermi, allergy sufferers can finally find relief through a convenient and personalized solution.
Contacts

Phone number

Social url